Supplementary Appendix - Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a COVID-19 Outbreak
Published: 23 July 2020| Version 1 | DOI: 10.17632/hwf6mwdccj.1
Contributor:
Jesse VeenstraDescription
Supplemental figures and tables
Files
Categories
Dermatology, Immunosuppressive Therapy, Immune-Mediated Illness, COVID-19